Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use Disorder

Brezing, C. A., Sibai, M., Choi, C. J., Mitra, S., Mariani, J. J., Naqvi, N., Mahony, A. L., Brooks, D., Pavlicova, M., & Levin, F. R. (2023). Open-label pilot of lorcaserin (a serotonin 2C-receptor agonist) for cannabis use disorder. Journal of Substance Use, 29(4), 487–494. https://doi.org/10.1080/14659891.2023.2202760
Authors:
Christina A Brezing
Mohammad Sibai
C Jean Choi
Souparno Mitra
John J Mariani
Nasir Naqvi
Amy L Mahony
Daniel Brooks
Martina Pavlicova
Frances R Levin
Affiliated Authors:
Christina A Brezing
John J Mariani
Nasir Naqvi
Martina Pavlicova
Frances R Levin
Columbia Affiliation:
Subjects:
Pharmacological Management of Obesity (OpenAlex Topic)
Endocannabinoid System and Its Effects on Health (OpenAlex Topic)
Attention-Deficit/Hyperactivity Disorder (OpenAlex Topic)
Author Keywords:
cannabis use disorder
lorcaserin
serotonin 2c agonist
sex differences
tolerability
elink
Publication Type:
Article
Unique ID:
10.1080/14659891.2023.2202760
PMID:
39021751
DOI:
10.1080/14659891.2023.2202760
Journal:
Journal of Substance Use
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record

Record Created: